Novartis to spin-off Sandoz business to a standalone company

Sandoz is planned to be incorporated in Switzerland and to be listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in the US

Kaléo announces appointments and new government business unit

Merck KGaA posts higher earnings, profits across business segments

Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million

Enveda appoints Vanitha Sekar as Chief Business Officer

She joins Enveda from Gilead Sciences

Bajaj Healthcare forays into the highly regulated - Opiate Processing Business for the GOI

The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.

We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region

Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing

DTx Pharma appoints Peter Condon as Chief Business Officer

Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.

Valo Therapeutics appoints Hemanshu Shah as Chief Business Officer

We see significant potential in working with oncolytic virus companies and Neo antigen-companies

ADC Therapeutics appoints David Gilman as Chief Business & Strategy Officer

Gilman will be responsible for all business development and portfolio strategy efforts globally.

GSK to form consumer healthcare business ‘Haleon’

The proposed demerger is the most significant corporate change for GSK in the last 20 years